Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry K Smith

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Chemmedchem|August 23, 2014
Non-natural acetogenin analogues as potent Trypanosoma brucei inhibitorsGordon J Florence, Andrew L Fraser, Eoin R Gould, et al.
Mbio|July 27, 2021
Turnover of Variant Surface Glycoprotein in Trypanosoma brucei Is a Bimodal ProcessPaige Garrison, Umaer Khan, Michael Cipriano, et al.
Bioorganic & Medicinal Chemistry|February 11, 2017
Simplifying nature: Towards the design of broad spectrum kinetoplastid inhibitors, inspired by acetogeninsEoin R Gould, Elizabeth F B King, Stefanie K Menzies, et al.
Plos Pathogens|October 23, 2018
Branched late-steps of the cytosolic iron-sulphur cluster assembly machinery of Trypanosoma bruceiMaiko Luis Tonini, Priscila Peña-Diaz, Alexander C Haindrich, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 10, 2017
6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: Design, synthesis and in vitro evaluationOndrej Benek, Lukas Hroch, Laura Aitken, et al.
Beilstein Journal of Organic Chemistry|July 8, 2025
<i>N</i>-Salicyl-amino acid derivatives with antiparasitic activity from <i>Pseudomonas</i> sp. UIAU-6BJoy E Rajakulendran, Emmanuel Tope Oluwabusola, Michela Cerone, et al.
Journal of Medicinal Chemistry|November 18, 2009
Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniasesLindsay B Tulloch, Viviane P Martini, Jorge Iulek, et al.
Nature Communications|December 19, 2023
A type VII-secreted lipase toxin with reverse domain arrangementStephen R Garrett, Nicole Mietrach, Justin Deme, et al.
Plos Pathogens|December 16, 2016
Vaccinia Virus Immunomodulator A46: A Lipid and Protein-Binding Scaffold for Sequestering Host TIR-Domain ProteinsSofiya Fedosyuk, Gustavo Arruda Bezerra, Katharina Radakovics, et al.
Plos Pathogens|July 11, 2024
Sterol 14-alpha demethylase (CYP51) activity in Leishmania donovani is likely dependent upon cytochrome P450 reductase 1Lindsay B Tulloch, Michele Tinti, Richard J Wall, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Chemmedchem|August 23, 2014
Non-natural acetogenin analogues as potent Trypanosoma brucei inhibitorsGordon J Florence, Andrew L Fraser, Eoin R Gould, et al.
Mbio|July 27, 2021
Turnover of Variant Surface Glycoprotein in Trypanosoma brucei Is a Bimodal ProcessPaige Garrison, Umaer Khan, Michael Cipriano, et al.
Bioorganic & Medicinal Chemistry|February 11, 2017
Simplifying nature: Towards the design of broad spectrum kinetoplastid inhibitors, inspired by acetogeninsEoin R Gould, Elizabeth F B King, Stefanie K Menzies, et al.
Plos Pathogens|October 23, 2018
Branched late-steps of the cytosolic iron-sulphur cluster assembly machinery of Trypanosoma bruceiMaiko Luis Tonini, Priscila Peña-Diaz, Alexander C Haindrich, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 10, 2017
6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: Design, synthesis and in vitro evaluationOndrej Benek, Lukas Hroch, Laura Aitken, et al.
Beilstein Journal of Organic Chemistry|July 8, 2025
<i>N</i>-Salicyl-amino acid derivatives with antiparasitic activity from <i>Pseudomonas</i> sp. UIAU-6BJoy E Rajakulendran, Emmanuel Tope Oluwabusola, Michela Cerone, et al.
Journal of Medicinal Chemistry|November 18, 2009
Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniasesLindsay B Tulloch, Viviane P Martini, Jorge Iulek, et al.
Nature Communications|December 19, 2023
A type VII-secreted lipase toxin with reverse domain arrangementStephen R Garrett, Nicole Mietrach, Justin Deme, et al.
Plos Pathogens|December 16, 2016
Vaccinia Virus Immunomodulator A46: A Lipid and Protein-Binding Scaffold for Sequestering Host TIR-Domain ProteinsSofiya Fedosyuk, Gustavo Arruda Bezerra, Katharina Radakovics, et al.
Plos Pathogens|July 11, 2024
Sterol 14-alpha demethylase (CYP51) activity in Leishmania donovani is likely dependent upon cytochrome P450 reductase 1Lindsay B Tulloch, Michele Tinti, Richard J Wall, et al.
Pageof 15